XOMA Royalty (XOMA) Non-Current Assets (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Non-Current Assets came in at $153.1 million in Q1 2026, up 53.84% year-on-year from $99.5 million in Q1 2025, and down 1.5% quarter-over-quarter from $155.4 million in Q4 2025.

XOMA Royalty (XOMA) Non-Current Assets (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Non-Current Assets across 17 years of filings, most recently posting $153.1 million for Q1 2026.

  • Non-Current Assets for Q1 2026 came in at $153.1 million, up 53.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $579.5 million (up 70.15% YoY), and the FY2025 annual result was $155.4 million, up 62.47% from the prior year.
  • Non-Current Assets came in at $153.1 million for Q1 2026 at XOMA Royalty, down from $155.4 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $155.4 million in Q4 2025 to a low of $64.3 million in Q3 2024.
  • The 5-year median for Non-Current Assets is $87.2 million (2023), against an average of $94.4 million.
  • Across the five-year window, Non-Current Assets declined 28.21% in 2024 and jumped 137.01% in 2025, its largest moves.
  • XOMA Royalty's Non-Current Assets stood at $79.1 million in 2022, then slipped by 17.87% to $65.0 million in 2023, then surged by 47.22% to $95.7 million in 2024, then surged by 62.47% to $155.4 million in 2025, then fell by 1.5% to $153.1 million in 2026.
  • The last three Non-Current Assets figures came in at $153.1 million (Q1 2026), $155.4 million (Q4 2025), and $152.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 62,953.78
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 4.56 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 486.60 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 30.30 Mn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 14.75 Bn
9 Abivax 95.45 Bn 95.45 Bn - 39.71 Mn
10 XOMA Royalty 5.52 Mn -60.56 Mn - 153.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 153.11 Mn
Dec 31, 2025 155.44 Mn
Sep 30, 2025 152.44 Mn
Jun 30, 2025 118.53 Mn
Mar 31, 2025 99.53 Mn
Dec 31, 2024 95.67 Mn
Sep 30, 2024 64.32 Mn
Jun 30, 2024 81.08 Mn
Mar 31, 2024 72.53 Mn
Dec 31, 2023 64.99 Mn
Sep 30, 2023 89.59 Mn
Jun 30, 2023 87.24 Mn
Mar 31, 2023 88.59 Mn
Dec 31, 2022 79.13 Mn
Sep 30, 2022 66.39 Mn
Jun 30, 2022 66.96 Mn
Mar 31, 2022 69.55 Mn
Dec 31, 2021 69.59 Mn
Sep 30, 2021 55.63 Mn
Jun 30, 2021 48.50 Mn